Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced the publication of a study in the Journal of Hepatology demonstrating the performance of HelioLiver™, ...

ORLANDO, Fla. (Ivanhoe Newswire) - Over 800,000 people are diagnosed with liver cancer every year worldwide, and it accounts for more than 700,000 cancer deaths each year. Traditional treatment ...

Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound waves. For some patients with liver cancer, they could be spared invasive ...

An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin.

NAFLD is prevalent in the U.S., often diagnosed incidentally due to absent screening guidelines, with significant implications for patient management. The study found that only 29% of patients with ...

Please provide your email address to receive an email when new articles are posted on . A heterogeneous ultrasound pattern may identify children with cystic fibrosis at high risk for development of ...

Scopics Announces New FDA Clearance for Hepatoscope® Expanding management of Liver disease complications. Company to exhibit at DDW 2026 Chicago.

Dorothy M. M. Kersten Professor of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Medical Director, Liver Transplantation Program, Cincinnati Children's Hospital Medical ...

Hoag acquired the newly-approved Edison Histotripsy System made by HistoSonics Hoag Memorial Hospital Presbyterian, one of Orange County’s largest hospitals, has implemented the latest in liver cancer ...

Early detection through screenings can help identify liver problems before they lead to significant damage.

Doctors can often diagnose liver cancer with a CT scan and blood tests. A biopsy may be needed if imaging results are inconclusive. Liver cancer is often diagnosed after someone develops symptoms such ...